Search Results
Luigino Dal Maso
Luigino Dal Maso
Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed
Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed
Daniela Pierannunzio
Daniela Pierannunzio
National Centre for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy
Search for other papers by Daniela Pierannunzio in
Google Scholar
PubMed
Search for other papers by Daniela Pierannunzio in
Google Scholar
PubMed
Silvia Francisci
Silvia Francisci
National Centre for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy
Search for other papers by Silvia Francisci in
Google Scholar
PubMed
Search for other papers by Silvia Francisci in
Google Scholar
PubMed
Angela De Paoli
Angela De Paoli
Epidemiological Department, Azienda Zero, Padova, Italy
Search for other papers by Angela De Paoli in
Google Scholar
PubMed
Search for other papers by Angela De Paoli in
Google Scholar
PubMed
Federica Toffolutti
Federica Toffolutti
Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
Search for other papers by Federica Toffolutti in
Google Scholar
PubMed
Search for other papers by Federica Toffolutti in
Google Scholar
PubMed
Salvatore Vaccarella
Salvatore Vaccarella
Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed
Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed
Silvia Franceschi
Silvia Franceschi
Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
Search for other papers by Silvia Franceschi in
Google Scholar
PubMed
Search for other papers by Silvia Franceschi in
Google Scholar
PubMed
Rossella Elisei
Rossella Elisei
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Ugo Fedeli
Ugo Fedeli
Epidemiological Department, Azienda Zero, Padova, Italy
Search for other papers by Ugo Fedeli in
Google Scholar
PubMed
Search for other papers by Ugo Fedeli in
Google Scholar
PubMed
of the DEPTH Working Group
of the DEPTH Working Group
of the DEPTH Working Group
Search for other papers by of the DEPTH Working Group in
Google Scholar
PubMed
Search for other papers by of the DEPTH Working Group in
Google Scholar
PubMed
Introduction Radioactive iodine (RAI) treatment may be used after total thyroidectomy (TT) for thyroid cancer for several purposes: remnant ablation to facilitate detection of recurrent disease, adjuvant treatment of subclinical residual tumor
Andries H Groen
Andries H Groen
Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
Search for other papers by Andries H Groen in
Google Scholar
PubMed
Search for other papers by Andries H Groen in
Google Scholar
PubMed
Deborah van Dijk
Deborah van Dijk
Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
Search for other papers by Deborah van Dijk in
Google Scholar
PubMed
Search for other papers by Deborah van Dijk in
Google Scholar
PubMed
Wim Sluiter
Wim Sluiter
Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
Search for other papers by Wim Sluiter in
Google Scholar
PubMed
Search for other papers by Wim Sluiter in
Google Scholar
PubMed
Thera P Links
Thera P Links
Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Hendrik P Bijl
Hendrik P Bijl
Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
Search for other papers by Hendrik P Bijl in
Google Scholar
PubMed
Search for other papers by Hendrik P Bijl in
Google Scholar
PubMed
John T M Plukker
John T M Plukker
Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
Search for other papers by John T M Plukker in
Google Scholar
PubMed
Search for other papers by John T M Plukker in
Google Scholar
PubMed
by radioactive iodine ( 131 I) and thyroid-stimulating hormone suppression therapy ( 2 , 3 , 4 ). However, 15–33% of DTC patients have a primary iodine refractory-differentiated thyroid cancer (IR-DTC) or develop IR-DTC after several sessions of
Furio Pacini
Furio Pacini
Section of Endocrinology, University of Siena, Siena, Italy
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Dagmar Fuhrer
Dagmar Fuhrer
Department of Endocrinology, Diabetes and Metabolism, West German Cancer Centre (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Rossella Elisei
Rossella Elisei
Section of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Daria Handkiewicz-Junak
Daria Handkiewicz-Junak
Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
Search for other papers by Daria Handkiewicz-Junak in
Google Scholar
PubMed
Search for other papers by Daria Handkiewicz-Junak in
Google Scholar
PubMed
Sophie Leboulleux
Sophie Leboulleux
Gustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, Cedex, France
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Markus Luster
Markus Luster
Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Martin Schlumberger
Martin Schlumberger
Gustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, Cedex, France
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Johannes W Smit
Johannes W Smit
Radboud University Medical Center, Nijmegen, Netherlands
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
iodine (RAI) therapy can be administered to patients with DTC for various indications. The non-descript colloquial use of the word 'ablation' has thus far frustrated a constructive scientific dialogue. While it has generally been recognized that the
Pepijn van Houten
Pepijn van Houten
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Pepijn van Houten in
Google Scholar
PubMed
Search for other papers by Pepijn van Houten in
Google Scholar
PubMed
James Nagarajah
James Nagarajah
Roentgeninstitut Duesseldorf, Duesseldorf, Germany
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by James Nagarajah in
Google Scholar
PubMed
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by James Nagarajah in
Google Scholar
PubMed
Janneke E W Walraven
Janneke E W Walraven
Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Janneke E W Walraven in
Google Scholar
PubMed
Search for other papers by Janneke E W Walraven in
Google Scholar
PubMed
Martin Jaeger
Martin Jaeger
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Adriana C H van Engen-van Grunsven
Adriana C H van Engen-van Grunsven
Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Adriana C H van Engen-van Grunsven in
Google Scholar
PubMed
Search for other papers by Adriana C H van Engen-van Grunsven in
Google Scholar
PubMed
Johannes W Smit
Johannes W Smit
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Romana T Netea-Maier
Romana T Netea-Maier
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Introduction The large majority of patients with non-medullary thyroid carcinoma (NMTC) have an excellent prognosis and achieve remission after conventional treatment by surgery, radioactive iodine (RAI) treatment, and levothyroxine
Andrew G Gianoukakis
Andrew G Gianoukakis
The Lundquist Institute at Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, California, USA
Search for other papers by Andrew G Gianoukakis in
Google Scholar
PubMed
Search for other papers by Andrew G Gianoukakis in
Google Scholar
PubMed
Jennifer H Choe
Jennifer H Choe
Department of Medicine, Duke University Medical Center/Duke Cancer Institute, Durham, North Carolina, USA
Search for other papers by Jennifer H Choe in
Google Scholar
PubMed
Search for other papers by Jennifer H Choe in
Google Scholar
PubMed
Daniel W Bowles
Daniel W Bowles
Division of Medical Oncology, University of Colorado, Aurora, Colorado, USA
Search for other papers by Daniel W Bowles in
Google Scholar
PubMed
Search for other papers by Daniel W Bowles in
Google Scholar
PubMed
Marcia S Brose
Marcia S Brose
Department of Otorhinolaryngology: Head and Neck Surgery, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by Marcia S Brose in
Google Scholar
PubMed
Search for other papers by Marcia S Brose in
Google Scholar
PubMed
Lori J Wirth
Lori J Wirth
Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA
Search for other papers by Lori J Wirth in
Google Scholar
PubMed
Search for other papers by Lori J Wirth in
Google Scholar
PubMed
Taofeek Owonikoko
Taofeek Owonikoko
Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Search for other papers by Taofeek Owonikoko in
Google Scholar
PubMed
Search for other papers by Taofeek Owonikoko in
Google Scholar
PubMed
Svetlana Babajanyan
Svetlana Babajanyan
Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA
Search for other papers by Svetlana Babajanyan in
Google Scholar
PubMed
Search for other papers by Svetlana Babajanyan in
Google Scholar
PubMed
Francis P Worden
Francis P Worden
Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, USA
Search for other papers by Francis P Worden in
Google Scholar
PubMed
Search for other papers by Francis P Worden in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) accounts for nearly 90% of all thyroid cancer cases ( 1 ). The standard initial treatment is surgery followed by radioactive iodine (RAI) or observation; however, approximately 5–15% of patients
Yasuhiro Ito
Yasuhiro Ito
Department of Surgery, Kuma Hospital, Shimoyamate-dori, Chuo-ku, Kobe, Hyogo, Japan
Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Akira Miyauchi
Akira Miyauchi
Department of Surgery, Kuma Hospital, Shimoyamate-dori, Chuo-ku, Kobe, Hyogo, Japan
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
-, and post-operative findings. They are useful in deciding therapeutic strategies, including the extent of surgery, adjuvant therapies such as radioactive iodine (RAI) administration, and postoperative follow-up imaging studies. Based on the 8th Edition
Lucie Allard
Lucie Allard
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Unité Thyroïde-Tumeurs Endocrines, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Lucie Allard in
Google Scholar
PubMed
Search for other papers by Lucie Allard in
Google Scholar
PubMed
Jérôme Alexandre Denis
Jérôme Alexandre Denis
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Service de Biochimie Endocrinienne et Oncologique, UF Oncobiologie Cellulaire et Moléculaire, Pitié Salpêtrière, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Jérôme Alexandre Denis in
Google Scholar
PubMed
Search for other papers by Jérôme Alexandre Denis in
Google Scholar
PubMed
Gaëlle Godiris Petit
Gaëlle Godiris Petit
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Service de Chirurgie Générale, Viscérale et Endocrinienne, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Gaëlle Godiris Petit in
Google Scholar
PubMed
Search for other papers by Gaëlle Godiris Petit in
Google Scholar
PubMed
Gabrielle Deniziaut
Gabrielle Deniziaut
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Service d’Anatomo-Pathologie, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Gabrielle Deniziaut in
Google Scholar
PubMed
Search for other papers by Gabrielle Deniziaut in
Google Scholar
PubMed
Cécile Ghander
Cécile Ghander
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Unité Thyroïde-Tumeurs Endocrines, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Elise Mathy
Elise Mathy
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Unité Thyroïde-Tumeurs Endocrines, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Elise Mathy in
Google Scholar
PubMed
Search for other papers by Elise Mathy in
Google Scholar
PubMed
Erell Guillerm
Erell Guillerm
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, UF d’Onco-Angiogénétique et Génomique des Tumeurs Solides, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Erell Guillerm in
Google Scholar
PubMed
Search for other papers by Erell Guillerm in
Google Scholar
PubMed
Charlotte Lussey-Lepoutre
Charlotte Lussey-Lepoutre
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Service de Médecine Nucléaire, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
Laurence Leenhardt
Laurence Leenhardt
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Unité Thyroïde-Tumeurs Endocrines, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Camille Buffet
Camille Buffet
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Unité Thyroïde-Tumeurs Endocrines, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Camille Buffet in
Google Scholar
PubMed
Search for other papers by Camille Buffet in
Google Scholar
PubMed
known for being predictive of radioiodine resistance ( 1 ). Considering both mutations and the patient’s advanced age and low autonomy, the multidisciplinary panel agreed to avoid iodine treatment. Post-operative 3-month evaluation showed an empty
Carla Colombo
Carla Colombo
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Daniele Ceruti
Daniele Ceruti
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Daniele Ceruti in
Google Scholar
PubMed
Search for other papers by Daniele Ceruti in
Google Scholar
PubMed
Simone De Leo
Simone De Leo
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Grzegorz Bilo
Grzegorz Bilo
Department of Cardiology, San Luca Hospital, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Grzegorz Bilo in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Grzegorz Bilo in
Google Scholar
PubMed
Matteo Trevisan
Matteo Trevisan
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Matteo Trevisan in
Google Scholar
PubMed
Search for other papers by Matteo Trevisan in
Google Scholar
PubMed
Noemi Giancola
Noemi Giancola
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Noemi Giancola in
Google Scholar
PubMed
Search for other papers by Noemi Giancola in
Google Scholar
PubMed
Claudia Moneta
Claudia Moneta
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Gianfranco Parati
Gianfranco Parati
Department of Cardiology, San Luca Hospital, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Gianfranco Parati in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Gianfranco Parati in
Google Scholar
PubMed
Luca Persani
Luca Persani
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Laura Fugazzola
Laura Fugazzola
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
-up of advanced radioiodine-refractory thyroid cancer . European Thyroid Journal 2019 8 227 – 245 . ( https://doi.org/10.1159/000502229 ) 2 Dadu R & Cabanillas ME . Optimizing therapy for radioactive iodine-refractory differentiated thyroid
João Roque
João Roque
Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal
Search for other papers by João Roque in
Google Scholar
PubMed
Search for other papers by João Roque in
Google Scholar
PubMed
Tiago Nunes Silva
Tiago Nunes Silva
Endocrinology, Diabetes and Metabolism Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
NOVA Medical School | Faculdade de Ciências Médicas of Universidade NOVA de Lisboa, Lisbon, Portugal
Unidade Investigação Patobiologia Molecular, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Tiago Nunes Silva in
Google Scholar
PubMed
NOVA Medical School | Faculdade de Ciências Médicas of Universidade NOVA de Lisboa, Lisbon, Portugal
Unidade Investigação Patobiologia Molecular, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Tiago Nunes Silva in
Google Scholar
PubMed
Catarina Regala
Catarina Regala
Endocrinology, Diabetes and Metabolism Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Catarina Regala in
Google Scholar
PubMed
Search for other papers by Catarina Regala in
Google Scholar
PubMed
Ricardo Rodrigues
Ricardo Rodrigues
Unidade Investigação Patobiologia Molecular, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Ricardo Rodrigues in
Google Scholar
PubMed
Search for other papers by Ricardo Rodrigues in
Google Scholar
PubMed
Valeriano Leite
Valeriano Leite
Endocrinology, Diabetes and Metabolism Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
NOVA Medical School | Faculdade de Ciências Médicas of Universidade NOVA de Lisboa, Lisbon, Portugal
Unidade Investigação Patobiologia Molecular, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
NOVA Medical School | Faculdade de Ciências Médicas of Universidade NOVA de Lisboa, Lisbon, Portugal
Unidade Investigação Patobiologia Molecular, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
, RAI avidity is quite variable in patients with PDTC, mainly due to the presence of less differentiated areas which decrease iodine-131 uptake and retention ( 1 , 4 ). EBRT can be considered after R2 surgery, loco-regionally recurrent disease, or bone
Hyunju Park
Hyunju Park
Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
Search for other papers by Hyunju Park in
Google Scholar
PubMed
Search for other papers by Hyunju Park in
Google Scholar
PubMed
Jung Heo
Jung Heo
Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang-si, Gyeonggi-do, Korea
Search for other papers by Jung Heo in
Google Scholar
PubMed
Search for other papers by Jung Heo in
Google Scholar
PubMed
Hyun Jin Ryu
Hyun Jin Ryu
Division of Endocrinology & Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Search for other papers by Hyun Jin Ryu in
Google Scholar
PubMed
Search for other papers by Hyun Jin Ryu in
Google Scholar
PubMed
Min-Ji Kim
Min-Ji Kim
Statistics and Data Center, Samsung Medical Center, Research Institute for Future Medicine
Search for other papers by Min-Ji Kim in
Google Scholar
PubMed
Search for other papers by Min-Ji Kim in
Google Scholar
PubMed
Young Lyun Oh
Young Lyun Oh
Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Search for other papers by Young Lyun Oh in
Google Scholar
PubMed
Search for other papers by Young Lyun Oh in
Google Scholar
PubMed
Tae Hyuk Kim
Tae Hyuk Kim
Division of Endocrinology & Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Search for other papers by Tae Hyuk Kim in
Google Scholar
PubMed
Search for other papers by Tae Hyuk Kim in
Google Scholar
PubMed
Sun Wook Kim
Sun Wook Kim
Division of Endocrinology & Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Search for other papers by Sun Wook Kim in
Google Scholar
PubMed
Search for other papers by Sun Wook Kim in
Google Scholar
PubMed
Jae Hoon Chung
Jae Hoon Chung
Division of Endocrinology & Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Search for other papers by Jae Hoon Chung in
Google Scholar
PubMed
Search for other papers by Jae Hoon Chung in
Google Scholar
PubMed
. Additionally, the prevalence of the BRAFV600E mutation in papillary thyroid carcinoma (PTC) ranges from 30% to greater than 80% ( 16 , 17 ), varying by geographic region and dietary components such as iodine intake ( 18 ). Thus, we conducted this study to
